CYDY · CytoDyn Inc. · Documents
$0.25
+0.00 (+0.04%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Oct 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company had an accumulated deficit of approximately $950.4 million as of August 31, 2026. These factors, among several others, raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Oct 14, 2026
Market Cap
$360.18M
Shares
1.47B
Volume · Oct 20
7.54M
Avg daily vol (3M)
1.68M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | CytoDyn appointed Robert E. Hoffman CEO effective October 20, 2026, while Jacob P. Lalezari resigned as CEO and became Head of Research and Translational Sciences. Hoffman will also remain principal accounting officer, with an annual base salary of $525,000. | 2026-10-19 | 2026-10-16 | |
| DEFA14A | CytoDyn appointed Robert E. Hoffman CEO effective October 20, 2026, while Jacob P. Lalezari became Head of Research and Translational Sciences. Preliminary CLOVER data reported ctDNA declines in 28 patients and shrinkage or stable disease in 38/51 (74.5%) patients with Week 8 scans. | 2026-10-19 | — | |
| 10-Q | CytoDyn Inc. reported a net loss of (19,936), in thousands, for the three months ended August 31, 2026, compared with (5,540), while cash and cash equivalents totaled $16.4 million against $49.7 million in short-term liabilities. | 2026-10-14 | 2026-08-31 | |
| DEF 14A | — | 2026-09-28 | — | |
| S-3 | — | 2026-09-25 | — | |
| 10-K | — | 2026-08-31 | 2026-05-31 | |
| 8-K | — | 2026-04-30 | — | |
| S-1 | — | 2026-04-22 | — | |
| 10-Q | — | 2026-04-08 | 2026-02-28 | |
| 8-K | — | 2026-03-24 | — | |
| 8-K | — | 2026-03-05 | 2026-02-27 | |
| 10-Q | — | 2026-01-09 | 2025-11-30 | |
| 8-K | — | 2025-12-01 | 2025-11-23 | |
| 8-K | — | 2025-11-21 | — | |
| S-3 | — | 2025-11-04 | — | |
| DEFA14A | — | 2025-11-03 | — | |
| 8-K | — | 2025-11-03 | — | |
| 10-Q | — | 2025-10-10 | 2025-08-31 | |
| DEFA14A | — | 2025-09-30 | — | |
| DEF 14A | — | 2025-09-29 | 2025-11-21 | |
| PRE 14A | — | 2025-09-19 | 2025-11-21 | |
| 10-K | — | 2025-07-25 | 2025-05-31 | |
| S-3 | — | 2025-07-25 | — | |
| 8-K | — | 2025-05-16 | 2025-05-14 | |
| 8-K | — | 2025-05-06 | 2025-05-02 | |
| 10-Q | — | 2025-04-14 | 2025-02-28 | |
| 10-Q | — | 2025-01-14 | 2024-11-30 | |
| 8-K | — | 2024-11-22 | — | |
| 10-Q | — | 2024-10-15 | 2024-08-31 | |
| DEF 14A | — | 2024-10-11 | 2024-11-22 | |
| 10-K/A | — | 2024-09-30 | 2024-05-31 | |
| S-1 | — | 2024-09-09 | — | |
| 10-K | — | 2024-08-15 | 2024-05-31 | |
| SC TO-I/A | — | 2024-07-22 | — | |
| 8-K | — | 2024-07-09 | 2024-07-02 | |
| SC TO-I/A | — | 2024-07-09 | — | |
| SC TO-I/A | — | 2024-06-28 | — | |
| 8-K | — | 2024-06-28 | — | |
| SC TO-I/A | — | 2024-06-20 | — | |
| SC TO-I | — | 2024-06-03 | — | |
| 8-K | — | 2024-06-03 | 2024-05-28 | |
| 8-K | — | 2024-05-06 | — | |
| 10-Q | — | 2024-04-15 | 2024-02-29 | |
| 8-K | — | 2024-04-08 | 2024-04-03 | |
| 8-K | — | 2024-03-28 | 2024-03-22 | |
| S-1 | — | 2024-02-07 | — | |
| 8-K | — | 2024-01-29 | 2024-01-23 | |
| 10-Q | — | 2024-01-16 | 2023-11-30 | |
| 8-K | — | 2023-12-22 | 2023-12-19 | |
| 8-K | — | 2023-12-14 | — |
Showing 1–50 of 219 filings